my Matt. and had QX, basis on versus points operating year, our start Slide our growth Gross remarks by higher-margin a reflecting Thanks, and double-digit strong X. segment. Recon XXX was in of Recon margin which quarter basis I'll points prepared XXX grew We highlighted margins expansion. prior faster-growing
of QX supply the As pressure. largely stabilized offset call, mentioned our in and were inflation in year, able back we the our half persistent to chain
performance, our Our QX EBITDA margins operating strong productivity cost management. of a result of and are XX.X%
of medical XXXX, lower-than-anticipated XX% onetime operating from benefited tax charges. in benefit growth. We than from greater also in favorable basis benefits from roughly Normalizing EPS strong points QX our expenses resulted underlying XX performance
XX cost P&R margins gross tilting business the equation by year, mix For our expanded progress basis our points, on to Recon, in leveraging the full making strategically and we driven business. capabilities price our by EGX
As Matt by our commented earlier, EBITDA we points. XX margins basis increased
of our continue put We entering our EPS acquisitions. challenging strong headwinds to the in invest extremely for I'm We currency of a mostly team inflation, proud position growth in cost and and delivered foreign actions, us a negative battled XXXX. market and million growth from and double-digit way environment, $XX offset EBITDA and
Slide X progression quarterly XXXX. details our in
segment of the growth by growth was second strong per highlighted Recon X% sales year. day our in half XX% notably with performance Our the in
than were other a pre-COVID overall pre-COVID levels, grew year. market Recon little disruptions the market pressure demand throughout of & the levels. better cancellations, bit While In the staffing Recovery, and began versus to obstacles Prevention turn overall markets course corner
QX with slowdown Matt in mentioned, temporary experienced lower-than-normal a we as And volumes. clinic
outpace Our competition strong course our segments to of in the continue both segments. business resiliency and demonstrated we during XXXX,
margins inflation we as EBITDA improved throughout increased the the reduced Our impacts progressed. and year XXXX sequentially as mix net
from acquisitions. company improvement These average offset carry by points impacts of Our recent margins. than initial core basis margin was XXX less
they rapid to expected continue However, years. coming the scale in are to growth from
currency pressure about against half had the strategic pleased also primarily Overall, impacted execute with and the that to results, in of of we goals. XX back continue points are our us basis we We year. our negative
year X. projecting including organic to XXXX, we X% In X% growth. are strong operating Turning Slide to performance, another of
Recon year improvements normalized global in market double-digit and growth another environment markets. expect P&R We a in in moderate
margin adjusted currency saw $XXX year million We are expected consistent the to basis of with is to margins improvement expecting by in least estimated growth with QX points full of similar guidance, in phasing to of XXXX we X progression Quarterly $XXX resulting be negative at million rates of EBITDA. to offset XX points impact. an organic X
modest We improvement margin critical Recon $XX and investments by be versus million, with in prior is anticipate estimated in that investments along will to this currency segment. QX our in year. industry result events Depreciation roughly growth in impact, driven meetings
interest of increases to $XX rates, expense interest expect rate our run resulting in XXXX. from remain similar slight XXXX second interest million approximately We half with in higher to
in XXXX effective XXXX separation, included we benefits a onetime tax XX%. expect rate around to into the settle sustainable more our While from rate of tax
our to forecasting EPS the earnings adjusted are of share for results to $X.XX. to operational year-over-year from growth. in this and tax We X% interest, impacts Adjusting be per XX% $X.XX
have XX, a growth year first MedTech as summarize, strong we Slide on To company. a
company a margins. clear in both and a strategy created for growth the blocks building with have We sustainable outperformance and market
we and ample create to to value XXXX, in capacity demonstrated system M&A business have exciting Our pipeline and as continues targets of execute. an
questions. prepared remarks. our concludes for the call please up open That Danielle,